U.S. Environmental Protection Agency guidelines for carcinogen risk assessment: Past and future

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 3-15

  Wiltse, Jeanette ^a   Dellarco, Vicki L ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

cancer; carcinogen; risk assessment

Indexed keywords

CARCINOGEN; ENVIRONMENTAL CHEMICAL;

CANCER RISK; CARCINOGENESIS; DOSE RESPONSE; FUTUROLOGY; HUMAN; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0030250456     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90009-3     Document Type: Article

References (41)

1. Ashby J., Brady A., Elcombe C.R., Elliott B.M., Ishmael J., Odum J., Tugwood D., Keltle S., Purchase I.F.H. Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13:1994;1-117.
2. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res. 257:1991;229-306.
3. Barrett J.C. Mechanisms of action of known human carcinogens. Mechanisms of Carcinogenesis in Risk Identification. IARC Sci. Pubs., No. 116. 1992;115-134 International Agency for Research on Cancer, Lyon, France.
4. Barrett J.C. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ. Health Perspect. 100:1993;9-20.
5. Bogdanffy M.S., Dreef-van der Meulen H.C., Beems R.B., Feron V.J., Rickard R.W., Tyler T.R., Cascieri T.C. Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse. Fundam. Appl. Toxicol. 23:1994b;215-229.
6. Bogdanffy M.S., Tyler T.R., Vinegar M.B., Capanini R.W., Cascieri T.C. Chronic toxicity and oncogenicity study with vinyl acetate in the rat: in utero exposure in drinking water. Fundam. Appl. Toxicol. 23:1994c;206-214.
7. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M.L., Kmieck T.E., Vande Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science. 251:1991;802-804.
8. Chen C., Farland W. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. Butterworth B., Slaga T., Farland W., McClain M. Chemical Induced Cell Proliferation: Implications for Risk Assessment. 1991;481-499 Wiley-Liss, New York.
9. Clayson D.B., Mehta R., Iverson F. Oxidative DNA damage - The effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutation Res. 317:1994;25-42.
10. Cohen S.M., Ellwein L.B. Genetic errors, cell proliferation and carcinogenesis. Cancer Res. 51:1991;6493-6505.
11. Cunningham M.L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutation Res. 365:1996;59-69.
12. Froelich-Ammon S.J., Osheroff N. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270:1995;21429-21432.
13. Gaylor D.W., Kodell R.L. Linear interpolation algorithm for low dose risk ascessment of toxic substances. J. Environ. Pathol. Toxicol. 4:1980;305-312.
14. Goldsworthy T.L., Conolly R.B., Fransson-Steen R. Apoptosis and cancer risk assessment. Mutation Res. 365:1996;71-90.
15. Goodman J.I., Counts J.L. Hypomethylation of DNA: A possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis. Environ. Health Perspect. 5:(101 Suppl.):1993;169-172.
16. Hill R.N., Erdreich L.S., Paynter O.E., et al. Review: thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12:1989;629-697.
17. Hsu I.C., Metaff R.A., Sum T., Welsh J.A., Wang N.J., Harris C.C. Mutational hotspots in human hepatocellular carcinomas. Nature. 350:1991;427-428.
18. Krewski D., Gaylor D.W., Lutz W.K. Additivity to background and linear extrapolation. Olin S., Farland W., Park C., Rhomberg L., Scheuplein R., Starr T., Wilson J. Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives. 1995;105-121 ILSI Press, Washington, DC.
19. Lijinsky W., Riggs C.W., Walters R.T. Lack of effect of carcinogen treatment on development of tumours arising spontaneously in Fischer 344 rats. J. Toxicol. Environ. Health. 39:1993;527-538.
20. National Research Council (NRC). Risk Assessment in the Federal Government: Managing the Process, Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences. 1983;NRC, National Academy Press, Washington, DC.
21. National Research Council (NRC). Science and Judgment in Risk Assessment, Committee on Risk Assessment of Hazardous Air Pollutants, Commission on Life Sciences, NRC. 1994;National Academy Press, Washington, DC.
22. Pitot H.C. The role of receptors in multistage carcinogenesis. Mutation Res. 333:1995;3-14.
23. Shelby M.D., Zeiger E. The genetic toxicity of human carcinogens and its implications. Mutation Res. 234:1990;257-261.
24. Tennant R.W., French J.E., Spalding J.W. Transgenic mouse models provide new tools for identifying chemical carcinogens and assessing risk. Environ. Health Perspect. 103:(Suppl. 10):1995;942-951.
25. Tennant R.W., Spalding J.W., French J.E. Evaluation of transgenic bioassays for identifying carcinogens and non-carcinogens. Mutation Res. 365:1996;119-127.
26. Tucker J.D., Preston R.J. chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment. Mutation Res. 365:1996;147-159.
27. U.S. Environmental Protection Agency (USEPA). Interim procedures and guidelines for health risk and economic impact assessment of suspected carcinogens. Fed. Register. 41:1976;21402-21405.
28. U.S. Environmental Protection Agency (USEPA). Guidelines for carcinogen risk assessment. Fed. Register. 51:(185):1986a;33992-34003.
29. U.S. Environmental Protection Agency (USEPA). Guidelines for mutagenicity risk assessment. Fed. Register. 51:(185):1986b;34006-340012.
30. U.S. Environmental Protection Agency (USEPA). Guidelines for exposure assessment. Notice, Fed. Register. 57:(104):1991a;22888-22896.
31. 2u-Globulin: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat. September 1991b;118 Risk Assessment Forum, Washington DC. EPA/625/3-91/019f.
32. U.S. Environmental Protection Agency (USEPA). Guidelines for developmental toxicity risk assessment. Notice, Fed. Register. 56:(234):1992;63798-63826.
33. U.S. Environmental Protection Agency (USEPA). Draft report: Principles of neurotoxicity risk assessment. Notice, Fed. Register. 58:(148):1993;41556-41599.
34. U.S. Environmental Protection Agency (USEPA). Guidelines for reproductive toxicity risk assessment. 1994a;External Review Draft, Office of Research and Development, Washington, DC. EPA/600/AP-94/001.
35. U.S. Environmental Protection Agency (USEPA). Report on the Workshop on Cancer Risk Assessment Guidelines Issues. 1994b;. EPA/630/R-94/005a, November 1994.
36. U.S. Environmental Protection Agency (USEPA). Health Assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds, External Review Draft. 1994c;95 Office of Research and Development, Washington, DC. Vol. 3 of 3, EPA/600/BP-92/001c.
37. U.S. Environmental Protection Agency (USEPA). Policy for risk characterization, memorandum of Carol M. Browner. 1995;Administrator, March 21, 1995, Washington, DC.
38. U.S. Environmental Protection Agency (USEPA). Proposed Guidelines for carcinogen risk assessment. Fed. Register. 61:(79):1996;17960-18011.
39. Varmus H., Weinberg R.A. Genes and the Biology of Cancer. 1993;214 Scientific American Library, New York.
40. Williams J.R., Russell J., Dicello J.F., Mabry M.H. The genotype of the human cancer cell: implication for risk analysis. Mutation Res. 365:1996;17-42.
41. Yamasaki H. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutation Res. 365:1996;91-105.